Denis Hadjiliadis, M.D., MHS

Assistant Professor of Medicine
Associate Medical Director, Lung Transplantation Program

University of Pennsylvania Medical Center
Pulmonary, Allergy & Critical Care Division
835 West Gates Building
3600 Spruce Street
Philadelphia, PA 19104
tel: (215) 615-3871
fax: (215) 662-3226
email.: denis.hadjiliadis@uphs.upenn.edu

Education:

MD: University of Toronto, Toronto, Canada 1995

Residency: Internal Medicine, Mayo Graduate School of Medicine, Rochester, MN, 1995-8

Fellowship: Pulmonary and Critical Care, Duke University Medical Center, Durham, NC, 1998-01

M.H.S.: Master of Health Sciences, Duke University, Durham, NC, 2001

Fellowship: Lung Transplantation and Cystic Fibrosis, University of Toronto, Toronto, Canada, 2001-2

Dr Hadjiliadis is a member of the advanced lung disease team at the University of Pennsylvania. His main clinical interests include management of lung transplant recipients before and after lung transplantation, cystic fibrosis and respiratory problems in recipients of other organ transplants. Dr Hadjiliadis obtained a Masters degree in Health Sciences (clinical research and epidemiology). His main research interests include chronic rejection after lung transplantation, gastroesophageal reflux disease in advanced lung disease and lung transplant patients, choice of transplant operation in patients with advanced lung disease, and predictions of outcome in patients with cystic fibrosis and lung transplantation. Dr Hadjiliadis has participated in multiple retrospective and is the co-investigator in prospective studies assessing the problems described above

Representative publications:

D.Hadjiliadis, C.Chaparro, C.Gutierrez, M.P.Steele, L.G.Singer, R.D.Davis, T.K.Waddell, M.A.Hutcheon, S.M.Palmer, S.Keshavjee. Impact of lung transplant operation on bronchiolitis obliterans syndrome (BOS) in patients with chronic obstructive pulmonary disease (COPD). Am J Transplant 2006; 6:183-9.

R.Lingaraju, N.P.Blumenthal, R.M.Kotloff, J.D.Christie, V.N.Ahya, J.S.Sager, A.Pochettino, D.Hadjiliadis. Effects of Lung Allocation Score on waiting list rankings and transplant procedures. J Heart Lung Transplant 2006; 25:1167-70.

D.Hadjiliadis, L.F.Angel. Controversies in lung transplantation: are two lungs better than one? Semin Respir Crit Care Med 2006; 27:561-6.

D.Hadjiliadis. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest 2007; 131:1224-31.

V.N.Ahya, L.Douglas, C.Andreadis, S.Arnoldi, J.Svoboda, R.M.Kotloff, D.Hadjiliadis, J.S.Sager, J.D.Christie, Y.J.Woo, A.Pochettino, S.J.Schuster, E.A.Stadtmauer, D.E.Tsai. Correlation between elevated whole blood EBER EBV PCR and reduced incidence of acute lung allograft rejection. J Heart Lung Transplant 2007; 26:839-44.

D.Hadjiliadis, M.P.Steele, C.Chaparro, L.G.Singer, T.K.Waddell, M.A.Hutcheon, R.D.Davis, D.E.Tullis, S.M.Palmer, S.Keshavjee. Survival of lung transplant recipients with cystic fibrosis harboring panresistant bacteria other than B. cepacia, compared to patients harboring sensitive bacteria. J Heart Lung Transplant 2007; 26:834-8.

F.D’Ovidio, M.Mura, M. Tsang, T.K.Waddell, M.Hutcheon, L.Singer, D.Hadjiliadis, C.Chaparro, C.Gutierrez, A.Pierre, G.Darling, M.Liu, S.Keshavjee. Post-lung transplant bronchiolitis obliternas syndrome development is associated with bile acid aspiration. J Thorac Cardiovasc Surg 2005; 129:1144-52.

L.R.Young*, D.Hadjiliadis*, R.D. Davis, S.M.Palmer. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003; 124:1689-93. (*primary co-authors)

R.D.Davis, C.L.Lau, W.S.Eubanks, R.H.Messier, D.Hadjiliadis, M.P.Steele, S.M.Palmer. Improved lung allograft function following fundoplication in lung transplant patients with GERD. J Thorac Cardiovasc Surg 2003; 125:533-42.

D.Hadjiliadis, R.D.Davis, S.M.Palmer. Are bilateral lung transplant recipients at reduced risk for bronchiolitis obliterans syndrome (BOS)? Chest 2002; 122:1168-75.